SI1370513T1 - Malic acid addition salts of terbinafine - Google Patents

Malic acid addition salts of terbinafine

Info

Publication number
SI1370513T1
SI1370513T1 SI200230146T SI200230146T SI1370513T1 SI 1370513 T1 SI1370513 T1 SI 1370513T1 SI 200230146 T SI200230146 T SI 200230146T SI 200230146 T SI200230146 T SI 200230146T SI 1370513 T1 SI1370513 T1 SI 1370513T1
Authority
SI
Slovenia
Prior art keywords
malic acid
terbinafine
acid addition
addition salts
antimycotics
Prior art date
Application number
SI200230146T
Other languages
English (en)
Slovenian (sl)
Inventor
Danielle Giron
Jean-Louis Reber
Stefan Hirsch
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of SI1370513T1 publication Critical patent/SI1370513T1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • C07C211/30—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring the six-membered aromatic ring being part of a condensed ring system formed by two rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Seasonings (AREA)
SI200230146T 2001-02-07 2002-02-06 Malic acid addition salts of terbinafine SI1370513T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0103046.9A GB0103046D0 (en) 2001-02-07 2001-02-07 Organic Compounds
EP02704689A EP1370513B1 (de) 2001-02-07 2002-02-06 Apfelsäureadditionssalze von terbinafin
PCT/EP2002/001249 WO2002070455A1 (en) 2001-02-07 2002-02-06 Malic acid addition salts of terbinafine

Publications (1)

Publication Number Publication Date
SI1370513T1 true SI1370513T1 (en) 2005-10-31

Family

ID=9908301

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200230146T SI1370513T1 (en) 2001-02-07 2002-02-06 Malic acid addition salts of terbinafine

Country Status (28)

Country Link
US (2) US20040147603A1 (de)
EP (1) EP1370513B1 (de)
JP (1) JP4078206B2 (de)
KR (2) KR100859609B1 (de)
CN (1) CN1216034C (de)
AT (1) ATE294154T1 (de)
AU (1) AU2002238534C1 (de)
BR (1) BR0207077A (de)
CA (1) CA2437592A1 (de)
CZ (1) CZ20032132A3 (de)
DE (1) DE60203890T2 (de)
DK (1) DK1370513T3 (de)
EC (1) ECSP034713A (de)
ES (1) ES2240698T3 (de)
GB (1) GB0103046D0 (de)
HK (1) HK1060876A1 (de)
HU (1) HUP0303174A3 (de)
IL (2) IL157241A0 (de)
MX (1) MXPA03007072A (de)
NO (1) NO20033473L (de)
NZ (1) NZ527300A (de)
PL (1) PL204812B1 (de)
PT (1) PT1370513E (de)
RU (1) RU2289570C2 (de)
SI (1) SI1370513T1 (de)
SK (1) SK9992003A3 (de)
WO (1) WO2002070455A1 (de)
ZA (1) ZA200306029B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004004700A1 (en) * 2002-07-02 2004-01-15 Novartis Ag Methods for the treatment of sinusitis
GB0503942D0 (en) * 2005-02-25 2005-04-06 Novartis Ag Purification process
WO2007104474A1 (en) * 2006-03-10 2007-09-20 Novartis Ag Antifungal compositions comprising (1) a salt of terbinafine with malic acid and (2) malic acid
JP2009540019A (ja) 2006-06-14 2009-11-19 ドクター・レディーズ・ラボラトリーズ・リミテッド 局所組成物
TW201920110A (zh) 2009-01-16 2019-06-01 美商艾克塞里克斯公司 包含n-(4-{[6,7-雙(甲氧基)喹啉-4-基]氧基}苯基)-n'-(4-氟苯基)環丙烷-1,1-二甲醯胺之蘋果酸鹽之醫藥組合物及其用途
CN106106449A (zh) * 2016-06-21 2016-11-16 广西中烟工业有限责任公司 特比萘芬制剂及其在提高烟叶角鲨烯含量中的应用

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3507755A (en) * 1967-10-17 1970-04-21 Bayer Ag Process for the purification of acrylonitrile by distillation with side stream withdrawal and decantation
US4276125A (en) 1979-02-02 1981-06-30 Asahi Kasei Kogyo Kabushiki Kaisha Process for purification of crude olefinically unsaturated nitrile and condenser useful for same process
US4269667A (en) 1979-08-02 1981-05-26 Standard Oil Company Acrylonitrile purification by extractive distillation
DE3069633D1 (en) * 1979-08-22 1984-12-20 Sandoz Ag Propenylamines, processes for their production, pharmaceutical compositions containing them and their use as pharmaceuticals
KR850001603B1 (ko) 1980-12-03 1985-10-24 아사히 가세이 고오교오 가부시기가이샤 불포화 니트릴의 제조법
GB8608335D0 (en) 1986-04-04 1986-05-08 Pfizer Ltd Pharmaceutically acceptable salts
NZ227042A (en) * 1987-11-27 1991-05-28 Banyu Pharma Co Ltd Substituted alkylamine derivatives and pharmaceutical compositions
US6005001A (en) * 1991-05-20 1999-12-21 Novartis Ag (Formerly Sandoz Ag) Pharmaceutical composition
HU223343B1 (hu) * 1991-05-20 2004-06-28 Novartis Ag. Allil-amin-származékot tartalmazó gyógyászati készítmények és eljárás azok előállítására
HU219480B (hu) 1991-05-23 2001-04-28 Novartis Ag. Eljárás gombás körömmegbetegségek ellen helyileg alkalmazható, allil-amin-származékot tartalmazó gyógyászati készítmények előállítására
US5461068A (en) * 1993-09-29 1995-10-24 Corwood Laboratories, Inc. Imidazole derivative tincture and method of manufacture
DE4400770C1 (de) * 1994-01-13 1995-02-02 Lohmann Therapie Syst Lts Wirkstoffhaltiges Pflaster zur Abgabe von Estradiol mit mindestens einem Penetrationsverstärker, Verfahren zu seiner Herstellung und seine Verwendung
NZ280065A (en) * 1995-09-20 1998-04-27 Apotex Inc Preparation of n-alkyl-n-(1-naphthylmethyl)alk-2-en-4-ynylamine derivatives
WO1998043673A1 (en) 1997-03-31 1998-10-08 Johnson & Johnson Consumer Companies, Inc. Solvent system for enhanced penetration of pharmaceutical compounds
US6231875B1 (en) 1998-03-31 2001-05-15 Johnson & Johnson Consumer Companies, Inc. Acidified composition for topical treatment of nail and skin conditions
WO1999049895A2 (en) 1998-03-31 1999-10-07 Johnson And Johnson Consumer Companies, Inc. Method for increasing the permeability of horny human tissue
RU2224523C2 (ru) * 1998-07-24 2004-02-27 Сео Хонг Ю Водный раствор, содержащий желчную кислоту, и способ его получения
JP2000053681A (ja) 1998-08-10 2000-02-22 Sankyo Co Ltd 三環性複素環化合物を含有する抗菌剤
ES2203190T3 (es) 1999-10-22 2004-04-01 Richter Gedeon Vegyeszeti Gyar R.T. Procedimiento para la preparacion de (e)-n-metil-n-(1-naftil-metil)-6,6-dimetil-hept-2-en-4-inil-1-amina.
GB0014448D0 (en) 2000-06-13 2000-08-09 Novartis Ag Organic compounds
JP4899139B2 (ja) 2000-08-10 2012-03-21 株式会社ポーラファルマ 抗真菌医薬組成物
JP4803511B2 (ja) 2000-08-25 2011-10-26 株式会社ポーラファルマ 抗真菌医薬組成物
JP2002068975A (ja) 2000-08-25 2002-03-08 Pola Chem Ind Inc 抗真菌医薬組成物

Also Published As

Publication number Publication date
DE60203890D1 (de) 2005-06-02
DK1370513T3 (da) 2005-08-01
NO20033473L (no) 2003-09-17
HUP0303174A3 (en) 2008-03-28
AU2002238534B2 (en) 2005-09-29
US20040147603A1 (en) 2004-07-29
US20070088084A1 (en) 2007-04-19
WO2002070455A1 (en) 2002-09-12
PL204812B1 (pl) 2010-02-26
CN1216034C (zh) 2005-08-24
ZA200306029B (en) 2004-06-28
US7488759B2 (en) 2009-02-10
AU2002238534C1 (en) 2006-04-13
KR20080041756A (ko) 2008-05-13
CA2437592A1 (en) 2002-09-12
GB0103046D0 (en) 2001-03-21
CN1491206A (zh) 2004-04-21
RU2003126176A (ru) 2005-03-10
IL157241A0 (en) 2004-02-19
ES2240698T3 (es) 2005-10-16
MXPA03007072A (es) 2003-11-18
NO20033473D0 (no) 2003-08-05
IL157241A (en) 2009-06-15
PL362554A1 (en) 2004-11-02
DE60203890T2 (de) 2006-01-19
EP1370513A1 (de) 2003-12-17
EP1370513B1 (de) 2005-04-27
BR0207077A (pt) 2004-01-20
JP4078206B2 (ja) 2008-04-23
PT1370513E (pt) 2005-08-31
HUP0303174A2 (hu) 2003-12-29
JP2004523567A (ja) 2004-08-05
HK1060876A1 (en) 2004-08-27
ECSP034713A (es) 2003-09-24
ATE294154T1 (de) 2005-05-15
KR100859609B1 (ko) 2008-09-23
KR20030077606A (ko) 2003-10-01
SK9992003A3 (en) 2004-01-08
CZ20032132A3 (cs) 2003-10-15
RU2289570C2 (ru) 2006-12-20
NZ527300A (en) 2005-02-25

Similar Documents

Publication Publication Date Title
AU2002319814A1 (en) Substituted 1h-dihydropyrazoles, their preparation and use
AP1614A (en) New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents.
TW200621737A (en) 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
DE602004021472D1 (en) Pyrimiidinverbindungen
HK1068626A1 (en) Chemical compounds
AU2003228770A8 (en) Substituted pyrazolopyrimidines
MXPA05009682A (es) Metodos de radiofluorinacion de vectores biologicamente activos.
HK1048990A1 (en) Novel compounds.
IL171992A0 (en) Storage-stable fluorescent whitener formulations
DE60112330D1 (en) Pyrazolopyridinderivate
MY153763A (en) Quinazolinedione derivatives, preparation thereof and therapeutic uses thereof
TW200640911A (en) Novel, long acting betamimetics for the treatment of respiratory diseases
TW200744612A (en) New combination
UA93529C2 (ru) Соли и смеси 9-оксоакридин-10-уксусной кислоты c 1-алкиламино-1-дезоксиполиолами
HK1060876A1 (en) Malic acid addition salts of terbinafine.
WO2006023586A3 (en) Guanylhydrazone compounds, compositions, methods of making and using
DE60201074D1 (en) Pyrazolopyridinderivate
MXPA04005988A (es) 3,4-dihidro-1h-isoquinolin-2-il-derivados.
MXPA04005151A (es) Compuestos terapeuticos.
GB0309440D0 (en) Quinolone derivatives
HU0201195D0 (de)
WO2005123694A3 (en) Quinazolinone compounds for the treatment of cough
MXPA06000995A (es) Amidas novedosas de acido indolil-3-glioxilico sustituidas en el atomo de n, uso de las mismas como medicamento y metodo para la produccion de las mismas.
DE602004025965D1 (en) Phosphinsäurederivate
BR0314567A (pt) N-bromo-2-pirrolidona estável, métodos para prepará-la e seu uso